Clinical Trial Results:
A Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group
Study to Evaluate the Efficacy and Safety of 3 Fixed Doses of JNJ-37822681
Administered Twice Daily in Subjects With Schizophrenia
Summary
|
|
EudraCT number |
2007-007083-22 |
Trial protocol |
LT EE BG |
Global completion date |
01 Feb 2010
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
06 Jul 2016
|
First version publication date |
14 May 2015
|
Other versions |
|
Summary report(s) |
2007-007083-22_37822681SCH2002 (CR014737)_CSR Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.